This field guide is meant to serve as a tool for practitioners working with children at risk of infection or being sick with MDR TB. It should be considered complementary to existing recommendations.
Favorite
International Agencies
2016
This fact sheet provides general information on TB drug resistance.
Favorite
2016
This webinar was created for nurses, doctors, and other licensed medical professionals and public health professionals involved in managing cases of drug-resistant tuberculosis and evaluating contacts to drug-resistant tuberculosis cases.
Favorite
2015
The objectives of this document are to describe the best practices in engaging different health providers and partners in the management of drug-resistant TB patients and to describe the necessary components in planning and implementing a public-private mix for the management of drug-resistant TB.
Favorite
International Agencies
Managers and Supervisors
Policy Makers
2015
This document presents guidance on the design and implementation of surveys and surveillance systems to measure the burden and trends of drug-resistant tuberculosis.
Favorite
International Agencies
2015
This is the 20th global report on tuberculosis (TB) published by WHO in a series that started in 1997. It provides a comprehensive and up-to-date assessment of the TB epidemic and progress in implementing and financing TB prevention, care and control at global, regional and country levels using data reported by 200 countries and territories that account for over 99% of the world’s TB cases.
Favorite
International Agencies
Managers and Supervisors
Policy Makers
2015
This document highlights strategic directions to integrate digital health into TB prevention and care activities in support of WHO’s End TB Strategy.
Favorite
International Agencies
Managers and Supervisors
Policy Makers
2015
This document shares best practices in engagement of health care providers in programmatic management of drug-resistant tuberculosis that have been documented in different countries and regions and implemented by different stakeholders. Case studies presented in the document are lessons learned for scale-up of public-private mix for the management of drug-resistant TB at country level.
Favorite
Policy Makers
2015
This is the nineteenth global report on tuberculosis (TB) published by WHO in a series that started in 1997. It provides a comprehensive and up-to-date assessment of the TB epidemic and progress in implementing and financing TB prevention, care and control at global, regional and country levels using data reported by 200 countries and territories that account for over 99% of the world’s TB cases.
Favorite
International Agencies
Managers and Supervisors
Policy Makers
2014
This handbook is a reference tool for use by national tuberculosis (TB) program managers, clinicians and nurses, public health decision-makers and technical and implementing partners committed to the prevention, care, diagnosis and treatment of drug-resistant TB.
Favorite
Community Based Organizations
Health Educators/Communicators
International Agencies
2014
The purpose of this training toolkit is to build the capacity of health care workers to address and manage TB in children. The toolkit consists of ten modules. Topics include epidemiology of childhood TB, diagnosis, treatment, prevention, TB/HIV co-infection, multidrug-resistant TB, and community-based child TB management.
Favorite
International Agencies
2014
This Medscape CDC Expert Video Commentary features Dr. Sundari Mase discussing multidrug-resistant tuberculosis (MDR TB) and the recently released CDC guidelines for the use and monitoring of a new TB drug called bedaquiline.
Favorite
2014
This online course discusses critical principles and steps to facilitate treatment adherence for MDR-TB patients. The five A’s are: Assess, Advise, Agree, Arrange, and Assist.
Favorite
2013
This pocket guide is intended to be a resource for physicians and other health care professionals who provide care and treatment to patients with MDR TB. The guide is a revision of The PIH Guide to the Medical Management of MDR-TB that was published in 2003.
Favorite
2013
This report highlights the issues surrounding high prices and poor supply of the drugs needed to treat drug-resistant tuberculosis (DR-TB). The report provides an overview of available drug-resistant TB medicines, including drug sources, quality status, and price.
Favorite
International Agencies
Policy Makers
2013
